Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

ADDvance Pharma in Scandinavia AB

Closing information (x1000 DKK)

Closing information 2025/08 2024/08 2023/08
Turnover 13,780 Less Arrow 13,739 Less Arrow 12,702
Financial expenses 1 More Arrow 11 Less Arrow 0
Earnings before taxes 2,458 More Arrow 2,998 Less Arrow 2,630
EBITDA 2,231 More Arrow 2,904 Less Arrow 2,526
Total assets 9,131 Less Arrow 8,130 Less Arrow 7,230
Current assets 8,322 Less Arrow 5,721 More Arrow 5,815
Current liabilities 2,435 Less Arrow 1,573 More Arrow 3,294
Equity capital 6,233 Less Arrow 6,137 Less Arrow 3,616
- share capital 68 Less Arrow 66 Less Arrow 63
Employees (average) 2 Equal arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2025/08 2024/08 2023/08
Solvency 68.3% More Arrow 75.5% Less Arrow 50.0%
Turnover per employee 6,890 Less Arrow 6,870 Less Arrow 6,351
Profit as a percentage of turnover 17.8% More Arrow 21.8% Less Arrow 20.7%
Return on assets (ROA) 26.9% More Arrow 37.0% Less Arrow 36.4%
Current ratio 341.8% More Arrow 363.7% Less Arrow 176.5%
Return on equity (ROE) 39.4% More Arrow 48.9% More Arrow 72.7%
Change turnover -317 More Arrow 457 More Arrow 4,151
Change turnover % -2% More Arrow 3% More Arrow 49%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2025/08 2024/08 2023/08
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.